Last $1.55 USD
Change Today -0.07 / -4.32%
Volume 52.2K
CLRX On Other Exchanges
As of 2:59 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

collabrx inc (CLRX) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/11/13 - $6.75
52 Week Low
07/17/14 - $1.55
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for COLLABRX INC (CLRX)

Related News

No related news articles were found.

collabrx inc (CLRX) Related Businessweek News

No Related Businessweek News Found

collabrx inc (CLRX) Details

CollabRx, Inc. provides cloud-based expert systems to inform healthcare decision-making. The company’s cloud-based expert systems provide clinical knowledge to institutions, physicians, researchers, and patients for genomics-based medicine in cancer. It offers CollabRx Therapy Finder, a series of cancer-specific Web-based system applications that are accessed by physicians and patients. The company was formerly known as Tegal Corporation and changed its name to CollabRx, Inc. in September 2012. CollabRx, Inc. was founded in 1972 and is headquartered in San Francisco, California.

15 Employees
Last Reported Date: 06/9/14
Founded in 1972

collabrx inc (CLRX) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $285.1K
Chair of The Editorial Advisory Board, Editor...
Total Annual Compensation: $139.4K
Chief Operating Officer and Vice President
Total Annual Compensation: $13.8K
Vice President of Business Development and St...
Total Annual Compensation: $182.4K
Compensation as of Fiscal Year 2014.

collabrx inc (CLRX) Key Developments

CollabRx, Inc. Auditor Raises 'Going Concern' Doubt

CollabRx, Inc. filed its 10-K on Jun 09, 2014 for the period ending Mar 31, 2014. In this report its auditor, Burr, Pilger & Mayer LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

MedPage Today and CollabRx, Inc. Introduce CancerRx, a New Decision Support Mobile Application for Oncology

MedPage Today and CollabRx, Inc. announced the introduction of a new physician resource, CancerRx an IOS application designed to help oncologists and pathologists navigate the complex landscape of oncology therapeutic options. The initial focus of the app will be the molecular aspects of laboratory testing and therapy development in cancer, the foundation of precision oncology in which each patient's cancer treatment plan is individually tailored to reflect the genetic profile of their tumor. Precision oncology is the most promising area of cancer drug development and CancerRx will broadly enable and empower oncologists to use this approach in treating their patients. The CancerRx app offers expert-vetted guidance of treatment options for lung cancer, melanoma, metastatic breast cancer and colorectal cancer based on tumor genetic profiles, stage, and histology in addition to other important clinical parameters, as relevant, such as treatment history. All are developed in close collaboration with CollabRx's expert advisory network, which is composed of over 75 physicians, scientists, and researchers from the nation's most prestigious academic and medical institutions as well as thought leaders spanning diverse backgrounds. In addition to treatment options based on the current standard of care, CancerRx helps physicians identify the most relevant clinical trials of investigational therapies, and provides summaries and links to clinical findings published in top tier medical journals and presented at national conferences for oncologists and other physicians involved in the care of cancer patients. A special feature of CancerRx is a daily oncology newsfeed from MedPage Today, all with real-time over the air updates. MedPage Today users can easily access the CancerRx app with their existing MedPage usernames and passwords or can register as new users.

CollabRx, Inc. Presents at LD MICRO 4th Annual Micro-Cap Invitational, Jun-04-2014

CollabRx, Inc. Presents at LD MICRO 4th Annual Micro-Cap Invitational, Jun-04-2014 . Venue: Luxe Sunset Bel Air, 11461 Sunset Boulevard, Los Angeles, CA 90049, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLRX:US $1.55 USD -0.07

CLRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLRX.
View Industry Companies

Industry Analysis


Industry Average

Valuation CLRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.9x
Price/Book 1.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COLLABRX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at